Karyopharm Therapeutics Inc.
KPTI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001503802
In the last 90 days, Karyopharm Therapeutics Inc. insiders filed 0 open-market purchases and 2 sales; 96 institutions reported holding it in 13F filings for Q2 2026, worth $213.5M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Karyopharm Therapeutics Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 2 filings
- 2 insiders, $1.38K in total
- Insiders trading
- 2
- Net value
- −$1.38K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Karyopharm Therapeutics Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Abate Kristin | Chief Accounting Officer | 23,782 | Sep 2, 2026 | 7 |
| Poulton Stuart | EVP, Chief Development Officer | 94,632 | Jul 30, 2026 | 6 |
| Bohlin Garen G | Director | 18,517 | May 26, 2026 | 1 |
| Pakianathan Deepika | Director | 15,508 | May 26, 2026 | 1 |
| Greene Barry E | Director | 16,415 | May 26, 2026 | 1 |
| Schor Chen | Director | 15,508 | May 26, 2026 | 1 |
| Oliger Christy J. | Director | 15,508 | May 26, 2026 | 1 |
| Su Zhen | Director | 15,508 | May 26, 2026 | 1 |
| Paulson Richard A. | President and CEO | 269,747 | May 15, 2026 | 4 |
| Rangwala Reshma | EVP & Chief Medical Officer | 56,829 | May 15, 2026 | 4 |
| Mano Michael | EVP, CLO&Secretary | 94,398 | May 15, 2026 | 4 |
| Cheng Sohanya Roshan | EVP & Chief Commercial Officer | 107,940 | May 15, 2026 | 4 |
| Macomber Lori | EVP, CFO & Treasurer | 85,105 | Feb 4, 2026 | 3 |
| Mirza Mansoor Raza | Director | – | May 29, 2025 | 0 |
| Mason Michael | EVP, CFO & Treasurer | 391,054 | Sep 5, 2024 | 0 |
| Honig Peter | Director | – | May 25, 2023 | 0 |
| Mitchener Stephen | SVP, Chief Business Officer | 128,313 | Mar 2, 2023 | 0 |
| Shacham Sharon | Chief Scientific Officer | 958,131 | Mar 31, 2022 | 0 |
| Kauffman Michael | Director | 898,131Indirect | Mar 2, 2022 | 0 |
| Frenkel Ran | EVP, Chief Dev. Officer | 168,290 | Mar 2, 2022 | 0 |
| Shah Jatin | EVP, Chief Medical Officer | 129,450 | Feb 22, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 (view filing)4:57 PM ET | Sep 1 | 1 day | Abate KristinChief Accounting Officer | SSale | −19 | $2.02 | −$38.38 | −0.1%23.8K after | |
| Jul 30, 2026 (view filing)4:42 PM ET | Jul 28 | 2 days | Poulton StuartEVP, Chief Development Officer | SSale | −189 | $7.10 | −$1.34K | −0.2%94.6K after | |
| May 15, 2026 (view filing) | May 14 | 1 day | Poulton StuartEVP, Chief Development Officer | SSale | −403 | $9.50 | −$3.83K | −0.4%94.8K after | |
| May 15, 2026 (view filing) | May 14 | 1 day | Rangwala ReshmaEVP & Chief Medical Officer | SSale | −408 | $9.50 | −$3.88K | −0.7%56.8K after | |
| May 15, 2026 (view filing) | May 14 | 1 day | Cheng Sohanya RoshanEVP & Chief Commercial Officer | SSale | −324 | $9.50 | −$3.08K | −0.3%107.9K after | |
| May 15, 2026 (view filing) | May 14 | 1 day | Abate KristinChief Accounting Officer | SSale | −53 | $9.50 | −$503.5 | −0.2%23.8K after | |
| May 15, 2026 (view filing) | May 14 | 1 day | Paulson Richard A.President and CEO | SSale | −2.20K | $9.50 | −$20.9K | −0.8%269.7K after | |
| May 15, 2026 (view filing) | May 14 | 1 day | Mano MichaelEVP, CLO&Secretary | SSale | −266 | $9.50 | −$2.53K | −0.3%94.4K after | |
| Apr 22, 2026 (view filing) | Apr 21 | 1 day | Rangwala ReshmaEVP & Chief Medical Officer | SSale | −449 | $8.94 | −$4.01K | −0.8%56.3K after | |
| Mar 3, 2026 (view filing) | Mar 2 | 1 day | Abate KristinChief Accounting Officer | SSale | −559 | $9.41 | −$5.26K | −2.5%22.1K after | |
| Mar 3, 2026 (view filing) | Mar 2 | 1 day | Poulton StuartEVP, Chief Development Officer | SSale | −5.10K | $9.41 | −$48.0K | −5.1%94.3K after | |
| Mar 3, 2026 (view filing) | Mar 2 | 1 day | Cheng Sohanya RoshanEVP & Chief Commercial Officer | SSale | −4.60K | $9.41 | −$43.3K | −4.1%107.3K after | |
| Mar 3, 2026 (view filing) | Mar 2 | 1 day | Mano MichaelEVP, CLO&Secretary | SSale | −3.53K | $9.41 | −$33.2K | −3.6%94.0K after | |
| Mar 3, 2026 (view filing) | Mar 2 | 1 day | Rangwala ReshmaEVP & Chief Medical Officer | SSale | −5.07K | $9.41 | −$47.7K | −8.2%56.7K after | |
| Mar 3, 2026 (view filing) | Mar 2 | 1 day | Paulson Richard A.President and CEO | SSale | −12.4K | $9.41 | −$116.3K | −4.4%267.0K after | |
| Feb 19, 2026 (view filing) | Feb 17 | 2 days | Poulton StuartEVP, Chief Development Officer | SSale | −378 | $8.63 | −$3.26K | −0.4%99.4K after | |
| Feb 4, 2026 (view filing) | Feb 3 | 1 day | Macomber LoriEVP, CFO & Treasurer | SSale | −1.63K | $6.30 | −$10.2K | −1.9%85.1K after | |
| Jan 29, 2026 (view filing) | Jan 28 | 1 day | Abate KristinChief Accounting Officer | SSale | −50 | $7.03 | −$351.5 | −0.2%22.6K after | |
| Jan 22, 2026 (view filing) | Jan 21 | 1 day | Abate KristinChief Accounting Officer | SSale | −265 | $5.96 | −$1.58K | −1.2%22.6K after | |
| Oct 3, 2025 (view filing) | Oct 1 | 2 days | Abate KristinChief Accounting Officer | SSale | −362 | $6.30 | −$2.28K | −3.5%10.0K after | |
| Sep 16, 2025 (view filing) | Sep 15 | 1 day | Paulson Richard A.President and CEO | SSale | −1.26K | $6.43 | −$8.08K | −1.5%84.0K after | |
| Sep 16, 2025 (view filing) | Sep 15 | 1 day | Mano MichaelSVP, General Counsel&Secretary | SSale | −234 | $6.43 | −$1.50K | −1.1%21.4K after | |
| Sep 16, 2025 (view filing) | Sep 15 | 1 day | Poulton StuartEVP, Chief Development Officer | SSale | −401 | $6.43 | −$2.58K | −1.4%27.7K after | |
| Sep 16, 2025 (view filing) | Sep 15 | 1 day | Rangwala ReshmaEVP & Chief Medical Officer | SSale | −408 | $6.43 | −$2.62K | −1.4%29.4K after | |
| Sep 16, 2025 (view filing) | Sep 15 | 1 day | Cheng Sohanya RoshanEVP & Chief Commercial Officer | SSale | −325 | $6.43 | −$2.09K | −0.9%35.9K after | |
| Sep 16, 2025 (view filing) | Sep 15 | 1 day | Abate KristinChief Accounting Officer | SSale | −23 | $6.43 | −$147.89 | −0.2%10.4K after | |
| Sep 4, 2025 (view filing) | Sep 3 | 1 day | Abate KristinChief Accounting Officer | SSale | −12 | $6.78 | −$81.36 | −0.1%9.46K after | |
| Jul 30, 2025 (view filing) | Jul 29 | 1 day | Poulton StuartEVP, Chief Development Officer | SSale | −191 | $4.37 | −$834.67 | −0.7%27.2K after | |
| Jul 23, 2025 (view filing) | Jul 22 | 1 day | Abate KristinChief Accounting Officer | SSale | −238 | $4.00 | −$952 | −2.5%9.47K after | |
| May 7, 2025 (view filing) | May 6 | 1 day | Paulson Richard A.President and CEO | SSale | −236 | $7.12 | −$1.68K | −0.3%82.5K after | |
| Apr 24, 2025 (view filing) | Apr 23 | 1 day | Rangwala ReshmaEVP & Chief Medical Officer | SSale | −419 | $6.17 | −$2.59K | −1.4%28.9K after | |
| Apr 7, 2025 (view filing) | Apr 4 | 3 days | Paulson Richard A.President and CEO | SSale | −245 | $3.74 | −$916.3 | −0.3%82.7K after | |
| Mar 6, 2025 (view filing) | Mar 4 | 2 days | Cheng Sohanya RoshanEVP & Chief Commercial Officer | SSale | −3.44K | $6.29 | −$21.7K | −9.1%34.3K after | |
| Mar 6, 2025 (view filing) | Mar 4 | 2 days | Paulson Richard A.President and CEO | SSale | −11.7K | $6.29 | −$73.6K | −12.4%83.0K after | |
| Mar 6, 2025 (view filing) | Mar 4 | 2 days | Rangwala ReshmaEVP & Chief Medical Officer | SSale | −3.59K | $6.29 | −$22.6K | −10.9%29.3K after | |
| Mar 6, 2025 (view filing) | Mar 4 | 2 days | Poulton StuartEVP, Chief Development Officer | SSale | −3.55K | $6.29 | −$22.3K | −11.5%27.4K after | |
| Mar 6, 2025 (view filing) | Mar 4 | 2 days | Abate KristinChief Accounting Officer | SSale | −571 | $6.29 | −$3.59K | −5.6%9.71K after | |
| Mar 6, 2025 (view filing) | Mar 4 | 2 days | Mano MichaelSVP, General Counsel&Secretary | SSale | −2.79K | $6.29 | −$17.6K | −11.7%21.0K after | |
| Feb 19, 2025 (view filing) | Feb 18 | 1 day | Poulton StuartEVP, Chief Development Officer | SSale | −5.91K | $0.63 | −$3.73K | −1.8%320.7K after | |
| Feb 5, 2025 (view filing) | Feb 4 | 1 day | Paulson Richard A.President and CEO | SSale | −4.10K | $0.65 | −$2.66K | −0.4%1.12M after | |
| Jan 7, 2025 (view filing) | Jan 6 | 1 day | Paulson Richard A.President and CEO | SSale | −4.05K | $0.78 | −$3.16K | −0.4%1.12M after | |
| Dec 5, 2024 (view filing) | Dec 4 | 1 day | Paulson Richard A.President and CEO | SSale | −3.62K | $0.81 | −$2.93K | −0.3%1.13M after | |
| Nov 6, 2024 (view filing) | Nov 5 | 1 day | Paulson Richard A.President and CEO | SSale | −3.67K | $0.91 | −$3.34K | −0.3%1.13M after | |
| Oct 7, 2024 (view filing) | Oct 4 | 3 days | Paulson Richard A.President and CEO | SSale | −3.61K | $0.88 | −$3.17K | −0.3%1.14M after | |
| Sep 5, 2024 (view filing) | Sep 4 | 1 day | Mano MichaelSVP, General Counsel&Secretary | SSale | −3.97K | $0.72 | −$2.86K | −1.4%273.9K after | |
| Sep 5, 2024 (view filing) | Sep 4 | 1 day | Paulson Richard A.President and CEO | SSale | −3.67K | $0.72 | −$2.64K | −0.3%1.14M after | |
| Sep 5, 2024 (view filing) | Sep 4 | 1 day | Mason MichaelEVP, CFO & Treasurer | SSale | −7.05K | $0.72 | −$5.08K | −1.8%391.1K after | |
| Sep 5, 2024 (view filing) | Sep 4 | 1 day | Cheng Sohanya RoshanEVP & Chief Commercial Officer | SSale | −5.36K | $0.72 | −$3.86K | −1.3%404.1K after | |
| Aug 8, 2024 (view filing) | Aug 6 | 2 days | Paulson Richard A.President and CEO | SSale | −3.61K | $0.93 | −$3.36K | −0.3%1.14M after | |
| Jul 31, 2024 (view filing) | Jul 30 | 1 day | Poulton StuartEVP, Chief Development Officer | SSale | −2.88K | $1.06 | −$3.06K | −0.9%326.6K after |